Allen et al. show that a single psilocybin injection administered one year after traumatic brain injury restores behavioral function and normalizes 5-HT2A receptor signaling, while reducing microglial density in the prefrontal cortex in rats, highlighting its potential for patients with chronic TBI symptoms.
